Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chapter 11: Future directions in cervical pathology.

Mark E Sherman1

  • 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health/DHHS, 6120 Executive Boulevard, Rm. 7080, EPS MSC 7234, Bethesda, MD 20892-7234, USA. shermanm@mail.nih.gov

Journal of the National Cancer Institute. Monographs
|June 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of breast cancer risk factors on the tumor microenvironment: a morphological deep-learning analysis of three prospective cohorts.

NPJ breast cancer·2026
Same author

Multi‑scale immune and spatial profiling of sclerosing adenosis and surrounding breast tissue identifies an immune‑cold field phenotype associated with breast cancer risk.

Breast cancer research : BCR·2026
Same author

Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleeding.

Gynecologic oncology·2026
Same author

The Human Male Mammary Gland has Similar Epithelial Populations to Female but Distinct Composition and Transcriptional Properties.

bioRxiv : the preprint server for biology·2026
Same author

Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark Analysis.

JCO oncology advances·2026
Same author

Stat Bite: Recent trends in ovarian cancer among Non-Hispanic Black and Non-Hispanic White women.

Journal of the National Cancer Institute·2026
Same journal

Impact of WHO Classification of Tumours on cancer prevention, diagnosis, research, public health, and economics.

Journal of the National Cancer Institute. Monographs·2026
Same journal

Cancer epigenetics: unraveling etiology and mechanisms to advance prevention.

Journal of the National Cancer Institute. Monographs·2026
Same journal

Oncogenic infections: targets highly amenable to cancer prevention.

Journal of the National Cancer Institute. Monographs·2026
Same journal

The continuing importance of the IARC's international remit in cancer research.

Journal of the National Cancer Institute. Monographs·2026
Same journal

Environmental and occupational cancer: highlighting research contributions from the IARC on its 60th anniversary.

Journal of the National Cancer Institute. Monographs·2026
Same journal

Progress in identifying the preventable causes of human cancer: the experience of the IARC Monographs program.

Journal of the National Cancer Institute. Monographs·2026
See all related articles

Technological advancements have transformed cervical cancer screening. Future biologic discoveries will further revolutionize cervical neoplasia prevention and epidemiologic research.

Area of Science:

  • Gynecologic pathology
  • Epidemiologic research
  • Cervical cancer screening

Background:

  • Cervical cytology has been significantly advanced by technological innovations.
  • Improved sampling devices, liquid-based cytology, and computer-assisted screening have revolutionized the field.
  • Understanding cervical neoplasia pathogenesis is evolving with new biologic discoveries.

Purpose of the Study:

  • To review the impact of recent and anticipated advances in pathology on cervical cancer screening.
  • To summarize opportunities and challenges for epidemiologic research in cervical cancer.
  • To highlight the transformative potential of future biologic discoveries.

Main Methods:

  • Review of technologic innovations in cervical cytology.

Related Experiment Videos

  • Analysis of recent and anticipated biologic discoveries in cervical neoplasia.
  • Assessment of implications for epidemiologic research.

    • Main Results:

    • Technologic innovations have already revolutionized cervical cytology.
    • Future biologic discoveries are poised to significantly alter screening and prevention strategies.
    • Advances present both opportunities and challenges for epidemiologic studies.

    Conclusions:

    • Cervical cancer screening is undergoing rapid transformation due to technological and biologic advances.
    • Epidemiologic research must adapt to leverage these changes for improved prevention.
    • The integration of pathology innovations is key to future progress.